(Q34506839)

2 August 2017

title

Catatonic signs in neuroleptic malignant syndrome (English)

1 reference

2 August 2017

Koch M

1

1 reference

2 August 2017

Chandragiri S

2

1 reference

2 August 2017

Rizvi S

3

1 reference

2 August 2017

Petrides G

4

1 reference

2 August 2017

Francis A

5

1 reference

2 August 2017

publication date

1 January 2000

1 reference

2 August 2017

published in

Comprehensive Psychiatry

1 reference

2 August 2017

volume

41

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

73-75

1 reference

Neuroleptic malignant syndrome and catatonia: one entity or two?

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2800%2990135-4

The nondichotomy between lethal catatonia and neuroleptic malignant syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2800%2990135-4

Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2800%2990135-4

7 January 2021

Serum iron in catatonia

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2800%2990135-4

Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2800%2990135-4

Catatonia and the neuroleptic malignant syndrome--a single entity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2800%2990135-4

Catatonia: a new indication for benzodiazepines?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2800%2990135-4

Case study: neuroleptic malignant syndrome without pyrexia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2800%2990135-4

Catatonia. I. Rating scale and standardized examination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2800%2990135-4

Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2800%2990135-4

Serum iron and neuroleptic malignant syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2800%2990135-4

Clinical electroencephalograms in patients with catatonic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2800%2990135-4

Plasma homovanillic acid concentrations in catatonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2800%2990135-4

Stupor and affective state: alleviation of psychomotor disturbances by lorazepam and recurrence of symptoms after Ro 15-1788.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2800%2990135-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0010-440X(00)90135-4

1 reference

2 August 2017

1 reference